Skip to main content
PLRZ
NASDAQ Industrial Applications And Services

Polyrizon Secures $4.0M via Registered Direct Offering and Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$11.01
Mkt Cap
$26.175M
52W Low
$2.88
52W High
$18.2
52W Position info
282% above low
Off High info
40% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

PLRZ has more than doubled off its 52-week low of $2.88 on elevated volume (2.2× avg).

Summary

Polyrizon Ltd. announced a $4.0 million registered direct offering and concurrent private placement with a single institutional investor, priced at $12.00 per share, expected to close September 4, 2026.


Key Events · Financing and Capital Events · PLRZ

  • $4.0M Registered Direct Offering

    A securities purchase agreement has been entered into for a $4.0 million registered direct offering and concurrent private placement with a single institutional investor.

  • Offering Terms

    The sale comprises 232,500 ordinary shares at $12.00 per share, 30,000 RDO pre-funded warrants at $11.99999 each, 70,833 PIPE pre-funded warrants, and 333,333 ordinary share warrants with a $12.00 exercise price and 5-year term.

  • Placement Agent Compensation

    Aegis Capital Corp. will receive an 8.0% cash placement fee on gross proceeds plus $75,000 for legal fees and disbursements.

  • Post-Offering Share Count

    Following completion, the company will have 2,806,233 ordinary shares issued and outstanding, assuming exercise of all pre-funded warrants.


Analysis · PLRZ · Industrial Applications And Services

A securities purchase agreement has been signed for a $4.0 million registered direct offering and concurrent private placement with a single institutional investor. The transaction includes 232,500 ordinary shares at $12.00 per share, 30,000 RDO pre-funded warrants, 70,833 PIPE pre-funded warrants, and 333,333 ordinary share warrants with a $12.00 exercise price. Notably, the offering price of $12.00 exceeds the current stock price of $11.01, indicating the investor paid a premium to today's market. Closing is expected on or about September 4, 2026, with proceeds earmarked for general corporate purposes and working capital. While this financing extends the runway for the development-stage biotech, the warrants introduce potential future dilution for existing shareholders.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PLRZ was trading at $11.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $26.2M. The 52-week trading range was $2.88 to $18.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PLRZ - Latest Insights

PLRZ
Sep 04, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.81
Real-time Price: $10.75 info
Change: -$0.0618 (-0.57%) info
Market Cap: $25.5M info
PLRZ
Sep 04, 2026, 9:16 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $11.01
Real-time Price: $10.75 info
Change: -$0.260 (-2%) info
Market Cap: $25.5M info
PLRZ
Sep 03, 2026, 8:50 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $12.01
Real-time Price: $10.75 info
Change: -$1.26 (-10%) info
Market Cap: $25.5M info
PLRZ
Sep 02, 2026, 7:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.22
Real-time Price: $10.75 info
Change: -$3.47 (-24%) info
Market Cap: $25.5M info
PLRZ
Aug 20, 2026, 4:00 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.96
Real-time Price: $10.75 info
Change: -$0.210 (-2%) info
Market Cap: $25.5M info